Patents-Review.com
ClassID:

170735 ⎘

G01N2440/10 - CPC Classification

Classification description:

Post-translational modifications [PTMs] in chemical analysis of biological material acylation, e.g. acetylation, formylation, lipoylation, myristoylation, palmitoylation

Recent Application in this class:
#1
20250298039
2025-09-25

METHODS AND COMPOSITIONS FOR TAUOPATHY DIAGNOSIS AND TREATMENT

 #2
20250179130
2025-06-05

METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS

 #3
20240376188
2024-11-14

MONOCLONAL ANTIBODIES TARGETING ACETYLATED TAU AND METHODS OF USE THEREOF

 #4
20240302388
2024-09-12

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DYING FROM BREAST CANCER OR PROSTATE CANCER

 #5
20240125804
2024-04-18

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES COMPRISING COX2 ACETYLATING AGENT AS ACTIVE INGREDIENT

 #6
20230213527
2023-07-06

COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS

 #7
20230212216
2023-07-06

SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE MODIFICATION OF PROTEINS

 #8
20230125690
2023-04-27

ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF

 #9
20230075784
2023-03-09

ANTI-MAA LMMUNOGLOBULIN ISOTYPES IN INFLAMMATORY BOWEL DISEASE: NOVEL DIAGNOSTIC IMPLICATIONS FOR ULCERATIVE COLITIS

 #10
20230020428
2023-01-19

Liquid Chromatography Assay for Determining AAV Capsid Ratio

 #11
20230016717
2023-01-19

Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry

 #12
20220146495
2022-05-12

METHODS AND AGENTS FOR ASSESSING T-CELL FUNCTION AND PREDICTING RESPONSE TO THERAPY

 #13
20220135633
2022-05-05

Soluble lipidated ligand agents for treating eye inflammation

 #14
20220091134
2022-03-24

REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE 2-HYDROXYISOBUTYRYLATION

 #15
20210215706
2021-07-15

SINGLE MOLECULE SEQUENCING IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATIONS ON PROTEINS

 #16
20210096053
2021-04-01

Method of analyzing post-translational modifications

 #17
20210055302
2021-02-25

Agents and methods for predicting response to therapy

 #18
20210003595
2021-01-07

Composition for diagnosis of degenerative neurological diseases

 #19
20210003594
2021-01-07

Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising COX2 acetylating agent as active ingredient

 #20
20200363416
2020-11-19

METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS

 #21
20200249224
2020-08-06

Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies

 #22
20200240995
2020-07-30

KDAC VARIANTS AND USES THEREOF

 #23
20190331695
2019-10-31

Reagents and methods for detecting protein lysine 3-hydroxybutyrylation

 #24
20190145986
2019-05-16

Reagents and methods for detecting protein lysine 2-hydroxyisobutyrylation

 #25
20190137512
2019-05-09

Reagents and methods for detecting protein crotonylation

 #26
20190135882
2019-05-09

Methods and systems for designing and/or characterizing soluble lipidated ligand agents

 #27
20190023808
2019-01-24

Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer

 #28
20180313826
2018-11-01

Circulating antibodies against MAA adducts as biomarker for coronary artery disease

 #29
20180259515
2018-09-13

Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications

 #30
20180011098
2018-01-11

METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS

 #31
20170362633
2017-12-21

NRAS related cancer therapy

 #32
20170307636
2017-10-26

BIOMARKER FOR DETERMINING MITOCHONDRIAL DAMAGE IN FRIEDREICH'S ATAXIA

 #33
20170173107
2017-06-22

Compstatin analogs with improved potency and pharmacokinetic properties

 #34
20170016902
2017-01-19

METHOD OF TREATING AND REDUCING THE RISK OF ACUTE MYELOGENOUS LEUKEMIA

 #35
20160209317
2016-07-21

Method of analyzing post-translational modifications

 #36
20160108135
2016-04-21

GHRELIN IN THE DIAGNOSIS OF CNS DISORDERS

 #37
20160090618
2016-03-31

CHARACTERIZATION OF THERMOSTABLE DNA POLYMERASE

 #38
20160052982
2016-02-25

Methods and systems for designing and/or characterizing soluble lipidated ligand agents

 #39
20160011177
2016-01-14

SCREENING METHOD FOR THERAPEUTIC AGENTS FOR CHARCOT-MARIE-TOOTH DISEASE AND SELF-DIFFERENTIATION MOTOR NEURONS USED THEREFOR

 #40
20150362507
2015-12-17

System and Methods of Detecting and Demonstrating Ultraviolet Damage to Hair Via Evaluation of Protein Fragments

 #41
20150276751
2015-10-01

REAGENT FOR IMAGING INTRACELLULAR ACETYLATION

 #42
20150241450
2015-08-27

Methods of detecting conjugation site-specific and hidden epitope/antigen

 #43
20150233949
2015-08-20

DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION

 #44
20150153352
2015-06-04

NEW BIOMARKERS TO ESTIMATE THE RISK OF ALLOGRAFT FAILURE AND PATIENT MORTALITY AFTER ORGAN TRANSPLANTATION

 #45
20150141361
2015-05-21

Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder

 #46
20150132769
2015-05-14

Biomarker for determining mitochondrial damage in friedreich's ataxia

 #47
20150065385
2015-03-05

REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION

 #48
20140348840
2014-11-27

Method of treating and reducing the risk of acute myelogenous leukemia

 #49
20140316105
2014-10-23

Method for modification of organic molecules

 #50
20130287838
2013-10-31

Vaccine engineering

 #51
20120270213
2012-10-25

Screening method for cell aging

 #52
20120165384
2012-06-28

INHIBITION OF HISTONE ACETYLTRANSFERASES BY CTK7A AND METHODS THEREOF

 #53
20120021924
2012-01-26

DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION

 #54
20100203647
2010-08-12

Chemical Reporters of Protein Acylation

 #55
20060040338
2006-02-23

Pharmacological profiling of drugs with cell-based assays